Vector-borne diseases, such as dengue, Zika and malaria, are a major cause of morbidity and mortality worldwide. These diseases have proven difficult to control and currently available management tools are insufficient to eliminate them in many regions. Gene drives have the potential to revolutionize vector-borne disease control. This suite of technologies has advanced rapidly in recent years as a result of the availability of new, more efficient gene editing technologies. Gene drives can favorably bias the inheritance of a linked disease-refractory gene, which could possibly be exploited (i) to generate a vector population incapable of transmitting disease or (ii) to disrupt an essential gene for viability or fertility, which could eventually eliminate a population. Importantly, gene drives vary in characteristics such as their transmission efficiency, confinability and reversibility, and their potential to develop resistance to the drive mechanism. Here, we discuss recent advancements in the gene drive field, and contrast the benefits and limitations of a variety of technologies, as well as approaches to overcome these limitations. We also discuss the current state of each gene drive technology and the technical considerations that need to be addressed on the pathway to field implementation. While there are still many obstacles to overcome, recent progress has brought us closer than ever before to genetic-based vector modification as a tool to support vector-borne disease elimination efforts worldwide.
Keywords: CRISPR; Cas9; ClvR; Homing drives; Medea; Split drive.
© 2020. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interestsThe authors declare no competing or financial interests.
Gene drives in our future: challenges of and opportunities for using a self-sustaining technology in pest and vector management.BMC Proc. 2018 Jul 19;12(Suppl 8):9. doi: 10.1186/s12919-018-0110-4. eCollection 2018. BMC Proc. 2018. PMID: 30079101 Free PMC article. Review.
Hot News: Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.AIDS Rev. 2017 Oct-Dec;19(3):167-172. AIDS Rev. 2017. PMID: 29019352
Gene Drive for Mosquito Control: Where Did It Come from and Where Are We Headed?Int J Environ Res Public Health. 2017 Sep 2;14(9):1006. doi: 10.3390/ijerph14091006. Int J Environ Res Public Health. 2017. PMID: 28869513 Free PMC article. Review.
Winning the Tug-of-War Between Effector Gene Design and Pathogen Evolution in Vector Population Replacement Strategies.Front Genet. 2019 Oct 30;10:1072. doi: 10.3389/fgene.2019.01072. eCollection 2019. Front Genet. 2019. PMID: 31737050 Free PMC article. Review.
Performance analysis of novel toxin-antidote CRISPR gene drive systems.BMC Biol. 2020 Mar 12;18(1):27. doi: 10.1186/s12915-020-0761-2. BMC Biol. 2020. PMID: 32164660 Free PMC article.